|
|
||||||||
Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee 53226, USA.
OBJECTIVES: The authors evaluated the cost-effectiveness of a community-level HIV prevention intervention that used peer leaders to endorse risk reduction among gay men. METHODS: A mathematical model of HIV transmission was used to translate reported changes in sexual behavior into an estimate of the number of HIV infections averted. RESULTS: The intervention cost $17,150, or about $65,000 per infection averted, and was therefore cost-saving, even under very conservative modeling assumptions. CONCLUSIONS: For this intervention, the cost of HIV prevention was more than offset by savings in averted future medical care costs. Community-level interventions to prevent HIV transmission that use existing social networks can be highly cost-effective.
This article has been cited by other articles:
![]() |
G. K. Ateka and D. R. Lairson School-Based HIV/STD Prevention Programs: Do Benefits Justify Costs? J Int Assoc Physicians AIDS Care (Chic Ill), February 1, 2008; 7(1): 46 - 51. [Abstract] [PDF] |
||||
![]() |
J. Hornberger, M. Holodniy, K. Robertus, M. Winnike, E. Gibson, and E. Verhulst A Systematic Review of Cost-Utility Analyses in HIV/AIDS: Implications for Public Policy Med Decis Making, December 1, 2007; 27(6): 789 - 821. [Abstract] [PDF] |
||||
![]() |
K. J. Sikkema HIV Prevention among Women in Low-Income Housing Developments: Issues and Intervention Outcomes in a Place-Based Randomized Controlled Trial The ANNALS of the American Academy of Political and Social Science, May 1, 2005; 599(1): 52 - 70. [Abstract] [PDF] |
||||
![]() |
A. P. Johnson-Masotti, P. W. Laud, R. G. Hoffmann, M. J. Hayat, and S. D. Pinkerton A Bayesian Approach to Net Health Benefits: An Illustration and Application to Modeling HIV Prevention Med Decis Making, November 1, 2004; 24(6): 634 - 653. [Abstract] [PDF] |
||||
![]() |
E. M. Howell, R. B. Greifinger, and A. S. Sommers What Is Known About the Cost-Effectiveness of Health Services for Returning Prisoners? Journal of Correctional Health Care, April 1, 2004; 10(3): 399 - 436. [Abstract] [PDF] |
||||
![]() |
S. D. Pinkerton and D. R. Holtgrave How HIV Treatment Advances Affect the Cost--Effectiveness of Prevention Med Decis Making, January 1, 2000; 20(1): 89 - 94. [Abstract] [PDF] |
||||
![]() |
S. K. Brodine, R. A. Shaffer, M. J. Starkey, S. A. Tasker, J. L. Gilcrest, M. K. Louder, A. Barile, T. C. VanCott, M. T. Vahey, F. E. McCutchan, et al. Drug Resistance Patterns, Genetic Subtypes, Clinical Features, and Risk Factors in Military Personnel with HIV-1 Seroconversion Ann Intern Med, October 5, 1999; 131(7): 502 - 506. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |